SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-005882
Filing Date
2021-05-17
Accepted
2021-05-17 16:11:08
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cvm_10q.htm   iXBRL 10-Q 866148
2 CERTIFICATIONS cvm_ex31.htm EX-31 19085
3 IN CONNECTION WITH THE QUARTERLY REPORT OF CEL-SCI CORPORATION (THE COMPANY ) ON cvm_ex32.htm EX-32 4450
  Complete submission text file 0001654954-21-005882.txt   4497914

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cvm-20210331.xsd EX-101.SCH 49922
5 XBRL CALCULATION FILE cvm-20210331_cal.xml EX-101.CAL 45409
6 XBRL DEFINITION FILE cvm-20210331_def.xml EX-101.DEF 113904
7 XBRL LABEL FILE cvm-20210331_lab.xml EX-101.LAB 279710
8 XBRL PRESENTATION FILE cvm-20210331_pre.xml EX-101.PRE 227106
9 EXTRACTED XBRL INSTANCE DOCUMENT cvm_10q_htm.xml XML 857767
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 21930669
SIC: 2836 Biological Products, (No Diagnostic Substances)